Patrick R. Blackburn PhD, FACMG, Frédéric Ebstein PhD, Tzung-Chien Hsieh PhD, Marialetizia Motta PhD, Francesca Clementina Radio MD, PhD, Johanna C. Herkert MD, PhD, Tuula Rinne PhD, Isabelle Thiffault PhD, Michele Rapp MS, Mariel Alders MD, PhD, Saskia Maas MD, Bénédicte Gerard PharmD, PhD, Thomas Smol MD, Catherine Vincent-Delorme MD, Benjamin Cogné MD, Bertrand Isidor MD, Marie Vincent MD, Ruxandra Bachmann-Gagescu MD, Anita Rauch MD, Pascal Joset PhD, Giovanni Battista Ferrero MD, PhD, Andrea Ciolfi PhD, Thomas Husson MD, PhD, Anne-Marie Guerrot MD, Carlos Bacino MD, FACMG, Colleen Macmurdo DO, Stephanie S. Thompson MS, CGC, Jill A. Rosenfeld MS, CGC, Laurence Faivre MD, PhD, Frederic Tran Mau-Them MD, PhD, Wallid Deb BSc, Virginie Vignard MS, Pankaj B. Agrawal MD, MMSc, Jill A. Madden PhD, MSc, CGC, Alice Goldenberg MD, François Lecoquierre MD, Michael Zech MD, Holger Prokisch PhD, Ján Necpál MD, Robert Jech MD, PhD, Juliane Winkelmann MD, Monika Turčanová Koprušáková MD, PhD, Vassiliki Konstantopoulou MD, John R. Younce MD, Marwan Shinawi MD, FACMG, Chloe Mighton MSc, Charlotte Fung MSc, CGC, Chantal F. Morel BSc, MD, FRCPC, Jordan Lerner-Ellis PhD, FACMG, Stephanie DiTroia PhD, Magalie Barth MD, Dominique Bonneau MD, PhD, Ingrid Krapels MD, PhD, Alexander P.A. Stegmann PhD, Vyne van der Schoot MD, PhD, Theresa Brunet MD, Cornelia Bußmann MD, Cyril Mignot MD, PhD, Giuseppe Zampino MD, Saskia B. Wortmann MD, PhD, Johannes A. Mayr MD, René G. Feichtinger PhD, Thomas Courtin MD, Claudia Ravelli MD, Boris Keren MD, PhD, Alban Ziegler MD, Linda Hasadsri MD, PhD, Pavel N. Pichurin MD, Eric W. Klee PhD, Katheryn Grand MS, CGC, Pedro A. Sanchez-Lara MD, MSCE, FAAP, FACMG, Elke Krüger PhD, Stéphane Bézieau PharmD, PhD, Hannah Klinkhammer MSc, Peter Michael Krawitz MD, PhD, Evan E. Eichler PhD, Marco Tartaglia PhD, Sébastien Küry DVM, PhD, Tianyun Wang PhD
{"title":"Loss-of-Function Variants in CUL3 Cause a Syndromic Neurodevelopmental Disorder","authors":"Patrick R. Blackburn PhD, FACMG, Frédéric Ebstein PhD, Tzung-Chien Hsieh PhD, Marialetizia Motta PhD, Francesca Clementina Radio MD, PhD, Johanna C. Herkert MD, PhD, Tuula Rinne PhD, Isabelle Thiffault PhD, Michele Rapp MS, Mariel Alders MD, PhD, Saskia Maas MD, Bénédicte Gerard PharmD, PhD, Thomas Smol MD, Catherine Vincent-Delorme MD, Benjamin Cogné MD, Bertrand Isidor MD, Marie Vincent MD, Ruxandra Bachmann-Gagescu MD, Anita Rauch MD, Pascal Joset PhD, Giovanni Battista Ferrero MD, PhD, Andrea Ciolfi PhD, Thomas Husson MD, PhD, Anne-Marie Guerrot MD, Carlos Bacino MD, FACMG, Colleen Macmurdo DO, Stephanie S. Thompson MS, CGC, Jill A. Rosenfeld MS, CGC, Laurence Faivre MD, PhD, Frederic Tran Mau-Them MD, PhD, Wallid Deb BSc, Virginie Vignard MS, Pankaj B. Agrawal MD, MMSc, Jill A. Madden PhD, MSc, CGC, Alice Goldenberg MD, François Lecoquierre MD, Michael Zech MD, Holger Prokisch PhD, Ján Necpál MD, Robert Jech MD, PhD, Juliane Winkelmann MD, Monika Turčanová Koprušáková MD, PhD, Vassiliki Konstantopoulou MD, John R. Younce MD, Marwan Shinawi MD, FACMG, Chloe Mighton MSc, Charlotte Fung MSc, CGC, Chantal F. Morel BSc, MD, FRCPC, Jordan Lerner-Ellis PhD, FACMG, Stephanie DiTroia PhD, Magalie Barth MD, Dominique Bonneau MD, PhD, Ingrid Krapels MD, PhD, Alexander P.A. Stegmann PhD, Vyne van der Schoot MD, PhD, Theresa Brunet MD, Cornelia Bußmann MD, Cyril Mignot MD, PhD, Giuseppe Zampino MD, Saskia B. Wortmann MD, PhD, Johannes A. Mayr MD, René G. Feichtinger PhD, Thomas Courtin MD, Claudia Ravelli MD, Boris Keren MD, PhD, Alban Ziegler MD, Linda Hasadsri MD, PhD, Pavel N. Pichurin MD, Eric W. Klee PhD, Katheryn Grand MS, CGC, Pedro A. Sanchez-Lara MD, MSCE, FAAP, FACMG, Elke Krüger PhD, Stéphane Bézieau PharmD, PhD, Hannah Klinkhammer MSc, Peter Michael Krawitz MD, PhD, Evan E. Eichler PhD, Marco Tartaglia PhD, Sébastien Küry DVM, PhD, Tianyun Wang PhD","doi":"10.1002/ana.27077","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>De novo variants in <i>cullin-3 ubiquitin ligase</i> (<i>CUL3</i>) have been strongly associated with neurodevelopmental disorders (NDDs), but no large case series have been reported so far. Here, we aimed to collect sporadic cases carrying rare variants in <i>CUL3</i>, describe the genotype–phenotype correlation, and investigate the underlying pathogenic mechanism.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Genetic data and detailed clinical records were collected via multicenter collaboration. Dysmorphic facial features were analyzed using GestaltMatcher. Variant effects on CUL3 protein stability were assessed using patient-derived T-cells.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We assembled a cohort of 37 individuals with heterozygous <i>CUL3</i> variants presenting a syndromic NDD characterized by intellectual disability with or without autistic features. Of these, 35 have loss-of-function (LoF) and 2 have missense variants. <i>CUL3</i> LoF variants in patients may affect protein stability leading to perturbations in protein homeostasis, as evidenced by decreased ubiquitin-protein conjugates in vitro. Notably, we show that 4E-BP1 (EIF4EBP1), a prominent substrate of CUL3, fails to be targeted for proteasomal degradation in patient-derived cells.</p>\n </section>\n \n <section>\n \n <h3> Interpretation</h3>\n \n <p>Our study further refines the clinical and mutational spectrum of <i>CUL3</i>-associated NDDs, expands the spectrum of cullin RING E3 ligase-associated neuropsychiatric disorders, and suggests haploinsufficiency via LoF variants is the predominant pathogenic mechanism. ANN NEUROL 2025;97:76–89</p>\n </section>\n </div>","PeriodicalId":127,"journal":{"name":"Annals of Neurology","volume":"97 1","pages":"76-89"},"PeriodicalIF":7.7000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ana.27077","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
De novo variants in cullin-3 ubiquitin ligase (CUL3) have been strongly associated with neurodevelopmental disorders (NDDs), but no large case series have been reported so far. Here, we aimed to collect sporadic cases carrying rare variants in CUL3, describe the genotype–phenotype correlation, and investigate the underlying pathogenic mechanism.
Methods
Genetic data and detailed clinical records were collected via multicenter collaboration. Dysmorphic facial features were analyzed using GestaltMatcher. Variant effects on CUL3 protein stability were assessed using patient-derived T-cells.
Results
We assembled a cohort of 37 individuals with heterozygous CUL3 variants presenting a syndromic NDD characterized by intellectual disability with or without autistic features. Of these, 35 have loss-of-function (LoF) and 2 have missense variants. CUL3 LoF variants in patients may affect protein stability leading to perturbations in protein homeostasis, as evidenced by decreased ubiquitin-protein conjugates in vitro. Notably, we show that 4E-BP1 (EIF4EBP1), a prominent substrate of CUL3, fails to be targeted for proteasomal degradation in patient-derived cells.
Interpretation
Our study further refines the clinical and mutational spectrum of CUL3-associated NDDs, expands the spectrum of cullin RING E3 ligase-associated neuropsychiatric disorders, and suggests haploinsufficiency via LoF variants is the predominant pathogenic mechanism. ANN NEUROL 2025;97:76–89
期刊介绍:
Annals of Neurology publishes original articles with potential for high impact in understanding the pathogenesis, clinical and laboratory features, diagnosis, treatment, outcomes and science underlying diseases of the human nervous system. Articles should ideally be of broad interest to the academic neurological community rather than solely to subspecialists in a particular field. Studies involving experimental model system, including those in cell and organ cultures and animals, of direct translational relevance to the understanding of neurological disease are also encouraged.